Nantahala Capital Management LLC Decreases Holdings in DarioHealth Corp. (NASDAQ:DRIO)

Nantahala Capital Management LLC reduced its stake in shares of DarioHealth Corp. (NASDAQ:DRIO) by 9.2% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,391,325 shares of the company’s stock after selling 241,234 shares during the period. Nantahala Capital Management LLC owned about 7.99% of DarioHealth worth $2,846,000 at the end of the most recent reporting period.

Separately, Clarity Capital Partners LLC purchased a new stake in DarioHealth in the fourth quarter worth $293,000. Institutional investors own 33.39% of the company’s stock.

DarioHealth Stock Up 5.2 %

Shares of NASDAQ DRIO opened at $1.12 on Tuesday. The stock has a market capitalization of $33.51 million, a PE ratio of -0.67 and a beta of 1.46. DarioHealth Corp. has a one year low of $0.68 and a one year high of $3.43. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.26 and a quick ratio of 1.96. The business’s fifty day moving average price is $0.94 and its 200-day moving average price is $1.24.

DarioHealth (NASDAQ:DRIO) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.43. DarioHealth had a negative net margin of 265.33% and a negative return on equity of 74.64%. The firm had revenue of $6.26 million for the quarter, compared to the consensus estimate of $7.57 million. On average, equities research analysts anticipate that DarioHealth Corp. will post -1.21 EPS for the current year.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.